Published in Medicine and Law Weekly, December 16th, 2005
Under the agreement, Eppendorf will have the right to manufacture and sell real-time thermal cyclers in the research and applied fields. Financial terms of the license were not disclosed.
"This agreement with Eppendorf further validates the significance of Applied Biosystems' real-time thermal cycler technology," said Paul D. Grossman, PhD, Esq, VP, Strategic Planning, Business Development and Intellectual Property for Applied Biosystems. "We may consider...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.